Vivozon Pharmaceutical Co., Ltd.

₩2,965As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:082800Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (5.78%)
Div yield —
ROE (33.67%)
Pharmaceutical Preparations
Beta (5Y) (0.53)
PE TTM —
TSR TTM (37.93%)
Mkt cap ₩178.4B
ROIC (8.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,978
0.43%
(40.91%)
Hold 5|0|12|10|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
30.48
30.40
30.61
31.47
3.67%
(2.33%)
0.99%
6.61%
Revenue₩B
10.09
9.902
9.996
10.09
(3.16%)
(3.75%)
0.10%
(2.40%)
Peers (US$131.5M)
Cap (US$)
PE
120.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.400
0.174
0.125
EBIT/Intx
1.289
1.645
1.611
Own earn%
47.04
(1.62)
(1.54)
Sh yield%
22.39
26.77
26.87
Owners
Insiders/Inst%
0.56
48.36
Short interest%
4.92
SBC / revenue%
4.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
22–28
$1 testx
−0.1
Incr. ROIC%
32